Fact CheckerSign in

NCT07336667Completed

The Effect of Robot-Assisted Gait Training With or Without Plantar Pressure Summary Feedback: Impact on Gait Symmetry and Balance in Hemiplegic Patients

족저압 요약 피드백 제공 유무에 따른 로봇보조보행훈련의 효과: 편마비 환자의 보행 대칭성과 균형에 미치는 영향; The Effect of Robot-Assisted Gait Training With or Without Plantar Pressure Summary Feedback: Impact on Gait Symmetry and Balance in Hemiplegic Patients

Source: ClinicalTrials.gov · Last updated 16 Jul 2026

Brief summary (registry, in English)

The goal of this randomized, single-blind clinical trial is to learn whether a 4-week Lokomat-based gait training program with plantar pressure feedback can improve gait symmetry and balance in adult patients with chronic hemiplegic stroke. The main questions it aims to answer are: Does Lokomat training with plantar pressure feedback improve spatiotemporal gait symmetry, as measured with the GAITRite system, more than Lokomat training without plantar pressure feedback? Does this intervention lead to greater improvements in balance and walking speed, assessed by the Berg Balance Scale (BBS) and the 10-Meter Walk Test (10MWT), compared with conventional Lokomat training? Researchers will compare a group receiving Lokomat training with both real-time feedback and additional summary plantar pressure feedback to a group receiving Lokomat training with real-time feedback only, to see if adding plantar pressure feedback results in superior gains in gait symmetry, balance, and walking ability. Participants will be adult inpatients with chronic hemiplegic stroke. They will be randomly assigned to one of the two training groups and will receive Lokomat-based gait training three times per week for 30 minutes per session over four weeks. Before and after the intervention period, participants will undergo gait analysis using the GAITRite walkway and clinical assessments including the BBS and 10MWT.

Status (registry)
Completed
Study type
Interventional
Enrollment
16 (actual)
First submitted
11 Dec 2025
Start date
5 Feb 2026
Primary completion date
29 Apr 2026
Lead sponsor
Yeonji Choi
Diseases
Stroke
NCT number
NCT07336667

What you commit to

  • Study type: Interventional
  • Participants enrolled: 16
  • From 5 Feb 2026 to the primary completion date, 29 Apr 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Lower limb surgery or fracture within the previous 3 months.
  • Acute or recurrent neurological events within the previous 3 months (e.g., recurrent cerebrovascular events).

Other illness

  • History of major psychiatric disorders such as schizophrenia, major depressive disorder, or bipolar disorder.
  • Uncontrolled cardiovascular or respiratory disease that makes gait training unsafe, such as uncontrolled hypertension, significant arrhythmia, angina, or acute exacerbation of respiratory disease.
  • Orthopedic or neuromuscular conditions that prevent safe robotic gait training, including:
  • Severe skin infection, pressure ulcer, or other skin condition at the harness or strap contact areas that makes physical contact difficult.
  • Any other medical condition that the principal investigator judges to make participation unsafe.
    • Vulnerable Populations:
    • This study includes only adult participants and does not enroll legally vulnerable populations such as minors or pregnant women. For inpatients, potential reduction in voluntariness due to relationships with treating clinicians is minimized by obtaining consent from a non-treating researcher, allowing sufficient time for decision-making, permitting withdrawal at any time without penalty, and allowing a caregiver to be present during the consent process if desired.

Other

  • MMSE score ≤ 23, indicating difficulty understanding the study procedures or expressing informed consent.
  • Moderate-to-severe joint contracture or severe spasticity (e.g., Modified Ashworth Scale ≥ 3).
  • Clinically significant leg-length discrepancy (≥ 2 cm).
  • Low back pain, dizziness, orthostatic hypotension, or other symptoms that prevent continuation of RAGT.

Who the study is looking for

  • Adult patients with hemiplegia after stroke who are currently admitted to or visiting the rehabilitation therapy department of Seoul Brain Hospital in Yeongdeungpo-gu, Seoul, Republic of Korea.
  • Chronic stage after stroke onset of at least 6 months.
  • Diagnosis of unilateral hemiplegia.
  • Mini-Mental State Examination(MMSE) score ≥ 24, with ability to understand the study procedures and provide informed consent.
  • Functional Ambulation Catefories(FAC) score of 1-2(FAC 0 excluded.)
  • Ability to communicate voluntarily for participation and consent.
  • Suiable physical condition for robot-assisted gait training(RAGT) and use of Lokomat device, including body weight ≤ 135 kg and height between approximately 150 cm and 2.0 m.

Age in the registry: 19 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Duksoo Medical Foundation Seoul Brain Hospital
Coordinator of this site? Confirm its status
SeoulSouth KoreaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.